Invasive breast carcinoma - IARC

2878. Tavassoli FA, Andradre R, Merino M
(1990). Retiform wolffian adenoma.
Progress in Surgical Pathology. Field &
Wood Medical Publishers: New York.
2879. Tavassoli FA, Norris HJ (1979).
Smooth muscle tumors of the vagina.
Obstet Gynecol 53: 689-693.
2 8 8 0 . Tavassoli FA, Norris HJ (1979).
Smooth muscle tumors of the vulva. Obstet
Gynecol 53: 213-217.
2 8 8 1 . Tavassoli FA, Norris HJ (1980).
Secretory carcinoma of the breast.Cancer
45: 2404-2413.
2882. Tavassoli FA, Norris HJ (1980). Sertoli
tumors of the ovary. A clinicopathologic
study of 28 cases with ultrastructural
observations. Cancer 46: 2281-2297.
2 8 8 3 . Tavassoli FA, Norris HJ (1981).
Mesenchymal tumours of the uterus. VII. A
clinicopathological study of 60 endometrial
stromal nodules. Histopathology 5: 1-10.
2 8 8 4 . Tavassoli FA, Norris HJ (1983).
Microglandular adenosis of the breast. A
clinicopathologic study of 11 cases with
ultrastructural observations. Am J Surg
Pathol 7: 731-737.
2 8 8 5 . Tavassoli FA, Norris HJ (1986).
Mammary adenoid cystic carcinoma with
sebaceous differentiation. A morphologic
study of the cell types. Arch Pathol Lab
Med 110: 1045-1053.
2886. Tavassoli FA, Norris HJ (1990). A
comparison of the results of long-term follow-up
for atypical intraductal hyperplasia
and intraductal hyperplasia of the breast.
Cancer 65: 518-529.
2 8 8 7 . Tavassoli FA, Norris HJ (1994).
Intraductal apocrine carcinoma: a clinicopathologic
study of 37 cases.Mod Pathol 7:
813-818.
2888. Tavassoli FA, Purcell CA, Bratthauer
GL, Man Y (1996). Androgen receptor
expression along with loss of bcl-2, ER and
PR expression in benign and malignant
apocrine lesions of the breast: implications
for therapy. Breast Jour 2: 261-269.
2 8 8 9 . Tavassoli FA, Weiss S (1981).
Hemangiopericytoma of the breast. Am J
Surg Pathol 5: 745-752.
2890. Tavassoli FA, Yeh IT (1988). Surgical
pathology of the ovary: a review of selected
tumors. Mod Pathol 1: 140-167.
2891. Tavtigian SV, Simard J, Rommens J,
Couch F, Shattuck-Eidens D, Neuhausen S,
Merajver S, Thorlacius S, Offit K, Stoppa-
Lyonnet D, Belanger C, Bell R, Berry S,
Bogden R, Chen Q, Davis T, Dumont M,
Frye C, Hattier T, Jammulapati S, Janecki
T, Jiang P, Kehrer R, Leblanc JF, Mitchell
JT, McArthur Morrisson J, Nguyen K, Peng
Y, Samson C, Shroeder M, Snyder SC,
Steele L, Stringfellow M, Stroup C,
Swedlund B, Swensen J, Teng D, Thomas
A, Tran T, Tran T, Tranchant M, Weaver
Feldhaus J, Wong AKC, Shizuya H, Eyfjord
JE, Cannon Albright L, Labrie F, Skolnick
MH, Weber B, Kamb A, Goldgar DE (1996).
The complete BRCA2 gene and mutations
in chromosome 13q-linked kindreds. Nat
Genet 12: 333-337.
2892. Taxy JB, Trujillo YP (1994). Breast
cancer metastatic to the uterus. Clinical
manifestations of a rare event. A r c h
Pathol Lab Med 118: 819-821.
2893. Taylor CE, Tuttle HK (1944).
Melanocarcinoma of the cervix uteri and
vaginal vault. Arch Pathol 38: 60-61.
2894. Taylor HB, Robertson A.G. (1965).
Adenomas of the nipple. Cancer 18: 995-
1002.
2894a. Taylor HCJ (1929). Malignant and
semimalignant tumors of the ovary. Surg
Gynecol Obstet 48: 204-230.
2895. Taylor RN, Lacey CG, Shuman MA
(1985). Adenocarcinoma of Skene's duct
associated with a systemic coagulopathy.
Gynecol Oncol 22: 250-256.
2896. Teilum G (1965). Endodermal sinus of
the ovary and testis: comparative morpho -
genesis of the so-called mesonephroma
ovarii (Schiller) and extraembryonic (yolk
sac allantoic) structures of the rat's palcenta.
Cancer 12: 1091-1105.
2897. Teixeira MR, Kristensen GB, Abeler
VM, Heim S (1999). Karyotypic findings in
tumors of the vulva and vagina. Cancer
Genet Cytogenet 111: 87-91.
2898. Tempany CM, Zou KH, Silverman SG,
Brown DL, Kurtz AB, McNeil BJ (2000).
Staging of advanced ovarian cancer: comparison
of imaging modalities--report from
the Radiological Diagnostic Oncology
Group. Radiology 215: 761-767.
2899. Terada S, Suzuki N, Uchide K, Shozu
M, Akasofu K (1993). Parovarian fibroma
with heterotopic bone formation of probable
wolffian origin. Gynecol Oncol 50: 115-
118.
2900. Terzakis JA, Opher E, Melamed J,
Santagada E, Sloan D (1990). Pigmented
melanocytic schwannoma of the uterine
cervix. Ultrastruct Pathol 14: 357-366.
2901. Tetu B, Bonenfant JL (1991). Ovarian
myxoma. A study of two cases with longterm
follow-up. Am J Clin Pathol 95: 340-
346.
2902. Tetu B, Silva EG, Gershenson DM
(1987). Squamous cell carcinoma of the
ovary. Arch Pathol Lab Med 111: 864-866.
2903. Tewari K, Cappuccini F, Disaia PJ,
Berman ML, Manetta A, Kohler MF (2000).
Malignant germ cell tumors of the ovary.
Obstet Gynecol 95: 128-133.
2904. Thakur S, Zhang HB, Peng Y, Le H,
Carroll B, Ward T, Yao J, Farid LM, Couch
FJ, Wilson RB, Weber BL (1997).
Localization of BRCA1 and a splice variant
identifies the nuclear localization signal.
Mol Cell Biol 17: 444-452.
2905. The European Commission (1996).
European Guidelines for Quality
Assurance in Mammography Screening.
2nd ed. The European Commission:
Luxembourg.
2906. Thomas DB, Jimenez LM, McTiernan
A, Rosenblatt K, Stalsberg H, Stemhagen
A, Thompson WD, Curnen MG, Satariano
W, Austin DF, et al. (1992). Breast cancer in
men: risk factors with hormonal implications.
Am J Epidemiol 135: 734-748.
2907. Thomas EJ, Campbell IG (2000).
Molecular genetic defects in endometriosis.
Gynecol Obstet Invest 50 Suppl 1: 44-
50.
2908. Thomas GM (2000). Concurrent
chemotherapy and radiation for locally
advanced cervical cancer: the new standard
of care. Semin Radiat Oncol 10: 44-50.
2909. Thomas HV, Key TJ, Allen DS, Moore
JW, Dowsett M, Fentiman IS, Wang DY
(1997). A prospective study of endogenous
serum hormone concentrations and breast
cancer risk in premenopausal women on
the island of Guernsey. Br J Cancer 75:
1075-1079.
2910. Thomas JP, Timbal Y, Wannin G,
Dumurgier C (1973). [Schwannoglioma of
the broad ligament]. J Urol Nephrol (Paris)
79: 933-935.
2911. Thomas M, Pim D, Banks L (1999).
The role of the E6-p53 interaction in the
molecular pathogenesis of HPV.
Oncogene 18: 7690-7700.
2912. Thomas NA, Choong DY, Jokubaitis
VJ, Neville PJ, Campbell IG (2001).
Mutation of the ST7 tumor suppressor
gene on 7q31.1 is rare in breast, ovarian
and colorectal cancers. Nat Genet 29: 379-
380.
2912a. Thomason RW, Rush W, Dave H
(1995). Transitional cell carcinoma arising
within a paratubal cyst: report of a case.
Int J Gynecol Pathol 14: 270-273.
2913. Thompson D, Easton D (2001).
Variation in cancer risks, by mutation position,
in BRCA2 mutation carriers. Am J
Hum Genet 68: 410-419.
2914. Thompson D, Easton D (2002).
Variation in BRCA1 cancer risks by mutation
position. Cancer Epidemiol Biomarkers
Prev 11: 329-336.
2915. Thompson D, Easton DF (2002).
Cancer incidence in BRCA1 mutation carriers.
J Natl Cancer Inst 94: 1358-1365.
2916. Thompson M, Husemeyer R (1981).
Carcinofibroma--a variant of the mixed
Mullerian tumour. Case report. Br J Obstet
Gynaecol 88: 1151-1155.
2917. Thompson ME, Jensen RA,
Obermiller PS, Page DL, Holt JT (1995).
Decreased expression of BRCA1 accelerates
growth and is often present during
sporadic breast cancer progression. Nat
Genet 9: 444-450.
2918. Thompson WD, Schildkraut JM
(1991). Family history of gynaecological
cancers: relationships to the incidence of
breast cancer prior to age 55. Int J
Epidemiol 20: 595-602.
2919. Thor AD, Young RH, Clement PB
(1991). Pathology of the fallopian tube,
broad ligament, peritoneum, and pelvic
soft tissues. Hum Pathol 22: 856-867.
2920. Thorlacius S, Sigurdsson S,
Bjarnadottir H, Olafsdottir G, Jonasson JG,
Tryggvadottir L, Tulinius H, Eyfjord JE
(1997). Study of a single BRCA2 mutation
with high carrier frequency in a small pop -
ulation. Am J Hum Genet 60: 1079-1084.
2921. Thorlacius S, Struewing JP, Hartge P,
Olafsdottir GH, Sigvaldason H,
Tryggvadottir L, Wacholder S, Tulinius H,
Eyfjord JE (1998). Population-based study
of risk of breast cancer in carriers of
BRCA2 mutation. Lancet 352: 1337-1339.
2922. Thurlbeck WM, Scully RE (1960).
Solid teratoma of the ovary. A clinicopathological
analysis of 9 cases. Cancer
13: 804-811.
2923. Tietze L, Gunther K, Horbe A, Pawlik
C, Klosterhalfen B, Handt S, Merkelbach-
Bruse S (2000). Benign metastasizing
leiomyoma: a cytogenetically balanced but
clonal disease. Hum Pathol 31: 126-128.
2924. Tiltman AJ (1980). Adenomatoid
tumours of the uterus. Histopathology 4:
437-443.
2925. Tiltman AJ (1998). Leiomyomas of the
uterine cervix: a study of frequency. Int J
Gynecol Pathol 17: 231-234.
2926. Tiltman AJ, Allard U (2001). Female
adnexal tumours of probable Wolffian origin:
an immunohistochemical study comparing
tumours, mesonephric remnants
and paramesonephric derivatives.
Histopathology 38: 237-242.
2927. Tirkkonen M, Kainu T, Loman N,
Johannsson OT, Olsson H, Barkardottir RB,
Kallioniemi OP, Borg A (1999). Somatic
genetic alterations in BRCA2-associated
and sporadic male breast cancer. Genes
Chromosomes Cancer 24: 56-61.
2928. Tjarks M, Van Voorhis BJ (2000).
Treatment of endometrial polyps. Obstet
Gynecol 96: 886-889.
2929. Tobon H, Murphy AI (1977). Benign
blue nevus of the vagina. Cancer 40: 3174-
3176.
2930. Todorov S (1980). Polyposis of the
uterine cervix. Jugosl Ginekol Opstet 19:
183-186.
2931. Tohya T, Katabuchi H, Fukuma K,
Fujisaki S, Okamura H (1991). Angiosarcoma
of the vagina. A light and electronmicroscopy
study. Acta Obstet
Gynecol Scand 70: 169-172.
2932. Toikkanen S (1981). Primary squamous
cell carcinoma of the breast. Cancer
48: 1629-1632.
2933. Toikkanen S, Eerola E, Ekfors TO
(1988). Pure and mixed mucinous breast
carcinomas: DNA stemline and prognosis.
J Clin Pathol 41: 300-303.
2934. Toikkanen S, Kujari H (1989). Pure
and mixed mucinous carcinomas of the
breast: a clinicopathologic analysis of 61
cases with long-term follow-up. H u m
Pathol 20: 758-764.
2935. Toikkanen S, Pylkkanen L, Joensuu H
(1997). Invasive lobular carcinoma of the
breast has better short- and long-term survival
than invasive ductal carcinoma. Br J
Cancer 76: 1234-1240.
2936. Toki T, Kurman RJ, Park JS, Kessis T,
Daniel RW, Shah KV (1991). Probable nonpapillomavirus
etiology of squamous cell
carcinoma of the vulva in older women: a
clinicopathologic study using in situ
hybridization and polymerase chain reaction.
Int J Gynecol Pathol 10: 107-125.
2937. Toki T, Zhai Y-L, Park JS, Fujii S
(1999). Infrequent occurence of high-risk
human papillomavirus and of p53 mutation
in minimal deviation adenocarcinoma of
the cervix. Int J Gynecol Pathol 18: 215-219.
2938. Tokunaga M, Land CE, Yamamoto T,
Asano M, Tokuoka S, Ezaki H, Nishimori I
(1987). Incidence of female breast cancer
among atomic bomb survivors, Hiroshima
and Nagasaki, 1950-1980. Radiat Res 112:
243-272.
2938a. Tommasino M (2001). Early genes of
human papillomaviruses. In: Encyclopedic
Reference of Cancer. Springer-Verlag:
Heidelberg, p. 270.
2939. Tonin P, Moslehi R, Green R, Rosen
B, Cole D, Boyd N, Cutler C, Margolese R,
Carter R, McGillivray B, Ives E, Labrie F,
Gilchrist D, Morgan K, Simard J, Narod SA.
(1995). Linkage analysis of 26 Canadian
breast and breast-ovarian cancer families.
Hum Genet 95: 545-550.
2940. Topalovski M, Crisan D, Mattson JC
(1999). Lymphoma of the breast. A clinicopathologic
study of primary and secondary
cases. Arch Pathol Lab Med 123: 1208-
1218.
2941. Tornos C, Silva EG, Khorana SM,
Burke TW (1994). High-stage endometrioid
carcinoma of the ovary. Prognostic significance
of pure versus mixed histologic
types. Am J Surg Pathol 18: 687-693.
418 References